For J&J OTC Sales,<em> Tylenol Arthritis</em> Label Approval Could Bring Relief Closer

For J&J OTC Sales, Tylenol Arthritis Label Approval Could Bring Relief Closer

FDA’s approval positions J&J/McNeil to return Tylenol 8HR Arthritis to the market with new packaging to interest consumers while also sustaining their connection with the iconic brand. The latest label design for the product features different color schemes and text fonts than the most recent previous changes.

FDA clearance of new labeling could signal a pending re-launch of Tylenol Arthritis Pain five years after McNeil Consumer Healthcare pulled it and other OTC drugs from the market in a spate of widespread recalls that later led to a consent decree.

FDA’s Center for Drug Evaluation and Research approved changes to the Johnson & Johnson business’s labeling for Tylenol 8HR...